ARTESE, Anna
 Distribuzione geografica
Continente #
NA - Nord America 3.571
AS - Asia 2.082
EU - Europa 1.177
SA - Sud America 363
AF - Africa 42
Continente sconosciuto - Info sul continente non disponibili 5
OC - Oceania 4
Totale 7.244
Nazione #
US - Stati Uniti d'America 3.458
SG - Singapore 945
CN - Cina 573
IT - Italia 531
BR - Brasile 272
IN - India 201
DE - Germania 184
VN - Vietnam 182
GB - Regno Unito 117
FI - Finlandia 94
SE - Svezia 83
CA - Canada 79
UA - Ucraina 53
HK - Hong Kong 46
AR - Argentina 43
BD - Bangladesh 25
ES - Italia 21
EE - Estonia 20
IQ - Iraq 19
ID - Indonesia 17
MX - Messico 17
ZA - Sudafrica 17
NL - Olanda 16
FR - Francia 15
JP - Giappone 13
CO - Colombia 11
EC - Ecuador 10
TR - Turchia 9
VE - Venezuela 8
CZ - Repubblica Ceca 7
DZ - Algeria 6
UY - Uruguay 6
EU - Europa 5
JO - Giordania 5
MA - Marocco 5
PL - Polonia 5
CL - Cile 4
DO - Repubblica Dominicana 4
EG - Egitto 4
GT - Guatemala 4
IR - Iran 4
KZ - Kazakistan 4
LT - Lituania 4
PE - Perù 4
SA - Arabia Saudita 4
TW - Taiwan 4
AL - Albania 3
KE - Kenya 3
PK - Pakistan 3
PR - Porto Rico 3
PY - Paraguay 3
RU - Federazione Russa 3
AE - Emirati Arabi Uniti 2
AF - Afghanistan, Repubblica islamica di 2
AT - Austria 2
CY - Cipro 2
DK - Danimarca 2
ET - Etiopia 2
HR - Croazia 2
IL - Israele 2
MD - Moldavia 2
MN - Mongolia 2
MY - Malesia 2
NG - Nigeria 2
NP - Nepal 2
NZ - Nuova Zelanda 2
PH - Filippine 2
PS - Palestinian Territory 2
PT - Portogallo 2
RO - Romania 2
SY - Repubblica araba siriana 2
TN - Tunisia 2
UZ - Uzbekistan 2
AM - Armenia 1
AU - Australia 1
BO - Bolivia 1
BY - Bielorussia 1
CH - Svizzera 1
CI - Costa d'Avorio 1
CR - Costa Rica 1
CU - Cuba 1
GE - Georgia 1
GP - Guadalupe 1
GR - Grecia 1
GY - Guiana 1
HN - Honduras 1
HU - Ungheria 1
IE - Irlanda 1
JM - Giamaica 1
KG - Kirghizistan 1
LB - Libano 1
LV - Lettonia 1
MK - Macedonia 1
PA - Panama 1
PW - Palau 1
QA - Qatar 1
SI - Slovenia 1
SK - Slovacchia (Repubblica Slovacca) 1
TH - Thailandia 1
Totale 7.244
Città #
San Jose 698
Dallas 557
Ashburn 361
Chandler 336
Singapore 250
Santa Clara 169
Munich 152
Hefei 143
Bengaluru 142
Milan 135
Lawrence 124
Princeton 124
Beijing 82
Ho Chi Minh City 76
London 75
Wilmington 70
Chicago 61
Helsinki 56
Ottawa 54
Des Moines 46
Hong Kong 45
Los Angeles 43
Catanzaro 41
Hanoi 36
Shanghai 28
Turku 28
São Paulo 27
New York 20
Rome 20
Washington 19
Boardman 17
Guangzhou 16
Brooklyn 15
Pune 15
San Francisco 15
Shenzhen 13
Johannesburg 12
Rio de Janeiro 11
Curitiba 10
Redmond 10
Tokyo 10
Chennai 9
Norwalk 9
Biên Hòa 8
Casoria 8
Orem 8
Phoenix 8
San Nicola Manfredi 8
Brasília 7
Cagliari 7
Haiphong 7
Naples 7
Olomouc 7
Toronto 7
Bari 6
Boston 6
Council Bluffs 6
Crotone 6
Guayaquil 6
Hanover 6
Jyväskylä 6
Messina 6
Montevideo 6
Montreal 6
Seattle 6
Weihai 6
Amman 5
Amsterdam 5
Atlanta 5
Catania 5
Charlotte 5
Columbus 5
Da Nang 5
Denver 5
Palermo 5
Redwood City 5
San Mateo 5
The Dalles 5
Wuhan 5
Anagni 4
Aversa 4
Baghdad 4
Bogotá 4
Buenos Aires 4
Buffalo 4
Dongyang 4
Erbil 4
Heidesheim 4
Hải Dương 4
Istanbul 4
Jiaxing 4
Lima 4
Luni 4
Mumbai 4
Porto Alegre 4
San Juan 4
Santander 4
Siena 4
Stockholm 4
Thái Bình 4
Totale 4.483
Nome #
(3Z)-3-(2-[4-(aryl)-1,3-thiazol-2-yl]hydrazin-1-ylidene)-2,3-dihydro-1H-indol-2-one derivatives as dual inhibitors of HIV-1 reverse transcriptase 206
A Candidate multi-targeting approach to block the CD98hc oncoprotein 111
Mediterranean products as promising source of multi-target agents in the treatment of metabolic syndrome 110
A drug repurposing screening reveals a novel epigenetic activity of hydroxychloroquine. 99
GBPM: applicazione al docking molecolare 93
Molecular recognition of a carboxy pyridostatin towards G-quadruplex structures: why does it prefer RNA? 91
Isolation and Functional Characterization of Peptide Agonists of PTPRJ, a Tyrosine Phosphatase Receptor Endowed with Tumor Suppressor Activity. 88
Back Cover: Hit Identification of a Novel Dual Binder for h-telo/c-myc G-Quadruplex by a Combination of Pharmacophore Structure-Based Virtual Screening and Docking Refinement (ChemMedChem 16/2016) 85
Ligand binding to telomeric G-quadruplex DNA investigated by funnel-metadynamics simulations 84
Abstract B122: The CD98hc oncoprotein as a target of new anticancer therapy 83
A Computational pathway toward the rational design of azinomycin analogues 83
Chromenone derivatives as a versatile scaffold with dual mode of inhibition of HIV-1 reverse transcriptase-associated Ribonuclease H function and integrase activity 81
Discovery of PTPRJ Agonist Peptides That Effectively Inhibit in Vitro Cancer Cell Proliferation and Tube Formation. 79
Computer-based techniques for lead identification and optimization II: Advanced search methods 78
Chemioterapici antifungini 76
Current status of antivirals and druggable targets of SARS CoV-2 and other human pathogenic coronaviruses 76
The Mediterranean Diet as source of bioactive compounds with multi-targeting anti-cancer profile 75
Identification and Characterization of New DNA G-Quadruplex Binders Selected by a Combination of Ligand and Structure-Based Virtual Screening Approaches 74
Aryl ethynyl anthraquinones: a useful platform for targeting telomeric G-quadruplex structures 71
In silico identification and biological evaluation of novel selective serum/glucocorticoid-inducible kinase 1 inhibitors based on the pyrazolo-pyrimidine scaffold 71
A Comparative Docking Strategy to Identify Polyphenolic Derivatives as Promising Antineoplastic Binders of G-quadruplex DNA c-myc and bcl-2 Sequences 71
SI113, a Specific Inhibitor of the Sgk1 Kinase Activity that Counteracts Cancer Cell Proliferation 69
Hit Identification of a Novel Dual Binder for h-telo/c-myc G-Quadruplex by a Combination of Pharmacophore Structure-Based Virtual Screening and Docking Refinement 68
Molecular recognition studies of dasabuvir, tegobuvir, and setrobuvir against natural Hepatitis C Virus NS5B polymerase variants. 67
TERRA G-quadruplex stabilization as a new therapeutic strategy for multiple myeloma 66
Characterization and Structural Analysis of Novel Mutations in HIV-1 Reverse Transcriptase Involved in the Regulation of Resistance to Non-Nucleoside Inhibitors 66
Chromene Derivatives as Selective TERRA G-Quadruplex RNA Binders with Antiproliferative Properties 65
In Silico Identification of Piperidinyl-amine Derivatives as Novel Dual Binders of Oncogene c-myc/c-Kit G-quadruplexes 65
Identification of G-quadruplex DNA/RNA binders: Structure-based virtual screening and biophysical characterization 65
In Silico-Guided Rational Drug Design and Synthesis of Novel 4-(Thiophen-2-yl)butanamides as Potent and Selective TRPV1 Agonists 64
Characterization of the role of two additional HIV-1 reverse transcriptase mutations in the regulation of NNRTI resistance 64
CoMFA studies of non covalent monoamine oxidase inhibitors 64
Comparison of molecular dynamics simulations carried out on wild type and mutants of HIV-1 reverse transcriptase 64
Novel natural non-nucleoside inhibitors of HIV-1 reverse transcriptase identified by shape- and structure-based virtual screening techniques 62
Identification of New Natural DNA G-Quadruplex Binders Selected by a Structure-Based Virtual Screening Approach 61
In silico identification and biological evaluation of antioxidant food components endowed with IX and XII hCA inhibition 61
A computer-assisted discovery of novel potential anti-obesity compounds as selective carbonic anhydrase VA inhibitors 61
Folding intermediate states of the parallel human telomeric G-quadruplex DNA explored using Well-Tempered Metadynamics 61
GBPM analysis of HIV-1 reverse transcriptase–DNA crystallographic complexes focused on the enzyme conserved regions of HAART-treated patients 60
From Homology Modeling to the Hit Identification and Drug Repurposing: A Structure-Based Approach in the Discovery of Novel Potential Anti-Obesity Compounds 59
Comparison of Computational Methods in Docking Experiments of G-Quadruplex Binders 58
Characterization and structural analysis of HIV-1 integrase conservation 58
Multi-targeting bioactive compounds extracted from essential oils as kinase inhibitors 58
An overview on olfaction in the biological, analytical, computational, and machine learning fields 58
Natural products extracted from fungal species as new potential anti-cancer drugs: A structure-based drug repurposing approach targeting HDAC7 57
Identification and Structural Characterization of Novel Genetic Elements in HIV-1 - V3 Loop Regulating Co-Receptor Usage 56
Computational analysis of human immunodeficiency virus (HIV) type-1 reverse transcriptase crystallographic models based on significant conserved residues found in highly active antiretroviral therapy (HAART)-treated patients 56
Computer-based techniques for lead identification and optimization i: Basics 56
Identification of new G-quadruplex binders by combined virtual screening approaches. 55
The Histone Deacetylase Family: Structural Features and Application of Combined Computational Methods 55
Correction: Curcio et al. The Histone Deacetylase Family: Structural Features and Application of Combined Computational Methods. Pharmaceuticals 2024, 17, 620 54
Metodi computazionali e nutraceutica 54
Conformational studies and solvent-accessible surface area analysis of known selective DNA G-Quadruplex binders 54
Hybrid ligand-alkylating agents targeting telomeric G-quadruplex structures 53
Composti per il G-quadruplex a struttura naftilimmidica 53
Indagine statistica sulla diffusione nell’Industria farmaceutica italiana di tecnologie computazionali avanzate orientate alla progettazione di nuovi farmaci 52
Hepatitis C Virus Genetic Variability and the Presence of NS5B Resistance-Associated Mutations as Natural Polymorphisms in Selected Genotypes Could Affect the Response to NS5B Inhibitors 52
Dinamica molecolare di complessi della proteasi di HIV-1: influenza di mutazioni associate a resistenza sulla ricognizione molecolare 52
Progettazione razionale di agenti bisalchilanti del DNA analoghi delle azinomicine 52
Targeting SARS-CoV-2 Main Protease: A Successful Story Guided by an In Silico Drug Repurposing Approach 51
Update on SARS-CoV-2 Omicron Variant of Concern and Its Peculiar Mutational Profile 51
Molecular and Structural Aspects of Clinically Relevant Mutations of SARS-CoV-2 RNA-Dependent RNA Polymerase in Remdesivir-Treated Patients 51
Targeting multiple G-quadruplex–forming DNA sequences: Design, biophysical and biological evaluations of indolo-naphthyridine scaffold derivatives 50
Molecular and structural aspects of clinically relevant mutations related to the approved non-nucleoside inhibitors of HIV-1 reverse transcriptase 49
Design, Synthesis, and Evaluation of New Tripeptides as COX-2 Inhibitors 49
Studi computazionali su modelli di Trascrittasi Inversa del virus HIV 49
Docking e virtual screening su composti naturali: esempi su quercitina e cucurbitacina 48
Computational analysis of HIV-1 reverse transcriptase complexes 48
Kaempferol as Selective Human MAO-A Inhibitor: Analytical Detection in Calabrian Red Wines, Biological and Molecular Modeling Studies 48
Structure-based virtual screening and molecular dynamics simulations of FDA-approved drugs targeting MALAT1 47
Computer-based techniques for lead identification and optimization I: Basics 47
Conformational analysis of bioactive conformations in the drug discovery process 46
Design and Synthesis of a (N-Alkylaminoalkyl-Substituted) Arylalkenylamide Drug Discovery Library 46
Key genetic elements, single and in clusters, underlying geographically dependent SARS-CoV-2 genetic adaptation and their impact on binding affinity for drugs and immune control 46
Hit Identification and Functional Validation of Novel Dual Inhibitors of HDAC8 and Tubulin Identified by Combining Docking and Molecular Dynamics Simulations 45
Incomplete APOBEC3G/F Neutralization by HIV-1 Vif Mutants Facilitates the Genetic Evolution from CCR5 to CXCR4 Usage 44
Computational study on DNA G-quadruplex binding compounds 44
Structural Modeling of New Polymorphism Clusters of HCV Polymerase Isolated from Direct-Acting Antiviral Naïve Patients: Focus on Dasabuvir and Setrobuvir Binding Affinity 44
Progettazione razionale e sintesi di prodotti di semplificazione molecolare delle azinomicine 44
Conformation and stability of intramolecular telomeric g-quadruplexes: sequence effects in the loops 43
Targeting unimolecular G-quadruplex nucleic acids: a new paradigm for the drug discovery? 43
Hit identification of novel small molecules interfering with MALAT1 triplex by a structure-based virtual screening 42
High-throughput lipophilicity screening of opioid-like analgesics: validation of computational methods by means of RP-HPLC analysis 42
Design and Synthesis of New Transient Receptor Potential Vanilloid Type-1 (TRPV1) Channel Modulators: Identification, Molecular Modeling Analysis, and Pharmacological Characterization of the N-(4-Hydroxy-3-methoxybenzyl)-4-(thiophen-2-yl)butanamide, a Small Molecule Endowed with Agonist TRPV1 Activity and Protective Effects against Oxidative Stress 42
Dependence of DNA sequence selectivity and cell cytotoxicity on azinomycin A and B epoxyamide stereochemistry 42
Docking comparativo nello sviluppo di ligandi per il DNA G-quadruplex 42
Hit identification of novel DNA-quadruplex ligands 41
The polymorphisms of DNA g-quadruplex investigated by docking experiments with telomestatin enantiomers 41
New Resistance Mutations to Nucleoside Reverse Transcriptase Inhibitors at Codon 184 of HIV-1 Reverse Transcriptase (M184L and M184T). 41
Docking studies of Lopinavir, Atazanavir and Darunavir binding modes to HIV-1 protease mutants 40
Structure-Based Virtual Screening of Novel Natural Alkaloid Derivatives as Potential Binders of h-telo and c-myc DNA G-Quadruplex Conformations 40
Molecular Recognition Of Dna G-Quadruplex Ligands By Different Docking Methods 40
Tetraplex DNA specific ligands based on the fluorenone-carboxamide scaffold 40
Fluorenone derivatives designed as selective binders of DNA G-Quadruplex 40
Computational approaches for discovery and optimization of G-quadruplex binders 40
Molecular dynamics and free energy studies on the wild-type and mutated HIV-1 protease complexed with four approved drugs: mechanism of binding and drug resistance 39
Hit identification and biological evaluation of anticancer pyrazolo-pyrimidines endowed with anti-inflammatory activity 39
Indagine statistica sulla diffusione delle tecnologie computazionali avanzate per la progettazione dei nuovi farmaci 39
STATISTICAL ANALISYS OF DRUG DESIGN COMPUTATIONAL TECNIQUES AMONG THE RESEARCH GROUPS IN ITALY 39
Different evolution of genotypic resistance profiles to emtricitabine versus lamivudine in tenofovir containing regimens 39
Totale 5.941
Categoria #
all - tutte 65.477
article - articoli 0
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 65.477


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2020/20214 0 0 0 0 0 0 0 0 0 0 0 4
2021/2022331 4 2 10 64 23 6 14 80 22 33 69 4
2022/2023997 253 48 46 71 111 72 9 70 154 58 81 24
2023/2024505 70 54 46 30 33 151 12 45 4 21 16 23
2024/20251.688 202 143 64 57 115 198 91 66 218 119 151 264
2025/20263.508 169 352 638 483 301 152 357 220 447 247 109 33
Totale 7.345